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Background:A solvent-preserved, mineralized human can-
cellous bone allograft (MBA) was recently developed. How-
ever, its effect in regenerating furcation defects remains to
be determined. Hence, the aim of the study is to evaluate the
effects of this newly introduced MBA, with and without a bioab-
sorbable collagen membrane, for the treatment of mandibular
class II furcation defects.
Methods: Thirty subjects with Hamp’s Class II buccal or lin-
gual furcation defects in lower molars were randomly assigned
to open flap debridement (OFD), MBA, or MBA with a bioab-
sorbable collagen membrane (guided tissue regeneration
[GTR] + MBA) groups. Clinical and defect measurements
were obtained at the initial visit and at 6-month reentry surger-
ies. The data were analyzed for intra- and intergroup compar-
isons and associations of treatment with probability of clinical
improvement.
Results: Out of a total of 30 subjects, 27 individuals com-
pleted the study. Vertical bone fill (VBF) was -1.6 – 2.1 mm
in OFD, 1.9 – 1.4 mm in MBA, and 0.7 – 0.9 mm in GTR +
MBA groups. VBF in MBA and GTR + MBA groups was signif-
icantly higher than that in the OFD group (P <0.05). Horizontal
bone fill (HBF) was 0.2 – 1.7 mm, 1.1 – 0.9 mm, and 1.1 –
0.9 mm for OFD, MBA, and GTR + MBA groups, respectively.
However, HBF, recession, clinical attachment level gain, and
probing depth reduction at furcations showed no differences
among groups.
Conclusions: Results obtained from this study indicate that
solvent-preserved, mineralized human cancellous allograft,
with or without collagen membrane, can significantly improve
bone fill in mandibular Class II furcation defects. In addition,
initial vertical defect depth was found to be the only factor
that was associated with a higher probability of clinical im-
provement. J Periodontol 2006;77:416-425.
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A
furcation defect has long been
recognized as one of the most dif-
ficult treatments in periodontal
therapy. Several non-surgical and sur-
gical therapies have been suggested and
attempted for managing this problem,
but the results have been largely unpre-
dictable.1-4 More recently, techniques
aimed at using bone grafts and/or barrier
materials have been evaluated in regen-
erating furcation defects.5,6 Encourag-
ing results have been shown in some
studies,7-10 but the ideal material to use
has not been unequivocally validated.
Allogenic bone graft materials have been
advocated due to their availability and
documented biologic activity.11,12 Min-
eralized solvent-dehydrated bone allo-
graft (MBA)‡ is a graft which contains
human mineralized component, organic
matrix, and collagen. MBA is preserved
by the Tutoplast process with solvent and
low-dose gamma irradiation. Solvent-
preserved MBA is the only allograft that
claims to preserve the trabeculation of
the bony structure by the manufacturer
and is shown to exhibit higher porosity
and inner surface areas than freeze-
dried bone allograft.13 Therefore, with
the potential of improved properties
for osteoconductivity, MBA has been
introduced to periodontal therapy and
recently has been evaluated for its use
in regenerative and bone augmentation
treatment.14,15 The objective of this ran-
domized, examiner-masked, controlled
study is to clinically evaluate the effects
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of a mineralized bone allograft material in treating
Class II furcation defects in mandibular molars.
MATERIALS AND METHODS
Patient Population
Thirty systemically healthy patients (mean age: 54.4
– 9.8 years; 12 females and 15 males) were recruited
from the patient population of the University of Mich-
igan, School of Dentistry from January 17, 2003
through July 20, 2004. Patient selection criteria for
this study included the following:1)systemicallyhealthy;
2) ‡30 years old; 3) patients who were willing to give
informed consent and to attend the study; 4) patients
who had a mandibular molar with Class II furcation in-
volvement (Hamp’s defect;1 horizontal loss of peri-
odontal support ‡3 but £7 mm); 5) no use of antibiotic
within 3 months prior to enrollment; 6) no known al-
lergies to the materials used in the study; 7) patients
must have completed initial phase of periodontal ther-
apy; 8) ability to maintain good oral hygiene (O’Leary
plaque score16 £20%); 9) width of keratinized tissue
‡1 mm; and 10) the tooth had no mobility (Miller17)
or mobility £ Class I. Patients with any of the following
conditions were excluded from the study: 1) confirmed
allergy to the graft material (confirmed by dermal
patch skin test18); 2) previous history of periodontal
regenerative therapy at the same site; 3) history of an-
tibiotic treatment for medical or dental reasons within
3 months prior to enrollment; 4) pregnant females or
those attempting to get pregnant; 5) clinically signif-
icant or unstable organic disease; 6) compromised
healing potential, such as connective tissue disorders,
heart murmurs, histories of rheumatic fever, valvular
disease, or prosthetic joint replacement necessitating
antibiotic prophylaxis; 7) active infectious disease,
such as hepatitis, human immunodeficiency virus,
or tuberculosis; 8) known metabolic bone disease
(e.g., osteoporosis and rheumatoid arthritis); 9) tak-
ing steroid medications except for acute topical treat-
ment; and 10) chronically treated (i.e., 2 weeks or
more) with any medications known to affect periodon-
tal status (e.g., phenytoin, calcium antagonist, cyclo-
sporin, coumadin, and non-steriodal antinflammatory
drugs) within 1 month of the screening examination.
All other medications for chronic medical conditions
were initiated at least 2 months prior to enrollment.
The use of human subjects in this study was ap-
proved by the Health Science Institutional Review
Board of the University of Michigan. All subjects had
reviewed and signed consent forms prior to entry in
the study.
Study Design
This was a controlled, randomized, examiner-masked
clinical trial with three parallel arms. The three arms of
the study were as follows: a mineralized human can-
cellous bone allograft (MBA) alone, MBA with colla-
gen membrane (guided tissue regeneration [GTR] +
MBA), and one control for open flap debridement
(OFD) alone for treatment of Class II mandibular fur-
cation defects. Presurgical treatments included oral
hygiene instructions, scaling and root planing, and/
or occlusal adjustment as indicated. Subjects were re-
quired to complete baseline examinations and then
randomly assigned into three groups during the sur-
gery after defect debridement. The randomization
was decided by drawing a piece of paper marked with
either A, B, or C (10 of each) from a brown bag. Sur-
gical procedures were either performed by or under
the supervision of one clinician (YPT).
Clinical Measurements
Probing depth (PD), clinical attachment level (CAL),
plaque index (PI; Silness and Löe19), gingival index
(GI; Löe20), and bleeding on probing (BOP; score:
no = 0 and yes = 1) were assessed at six sites (mesio-
buccal, mid-buccal, disto-buccal, mesio-lingual,
mid-lingual, and disto-lingual) for each study tooth
at baseline and 6 months. Additional clinical mea-
surements, such as horizontal probing depth (HPD) at
furcation, were recorded at the time of initial surgery
and at 6-month reentry surgery. Changes in furcation
status were assessed at 6 months after initial surgery.
Direct defect measurement was performed using a
prefabricated acrylic stent and a University of North
Carolina (UNC) probe; the stent was grooved at the
time of surgery to record the orientation of the probe.
When the stent was placed on the occlusal surface of
the tooth and adjacent teeth (Fig. 1), an occlusal
ledge served as an occlusal landmark. The following
measurements were included: stent to the free gingi-
val margin, stent to the base of defect (SB), crest of
bone to base of defect (CB), and bucco-lingual/
mesio-distal (BL/MD) morphology of the furcation
defects (Fig. 1). The bucco-lingual depth of the defect
was measured from the furcation entrance to the most
inner part of the defect. The mesio-distal depth of the
defect was measured at the crestal bone level. The
wound healing index (WHI21), to assess soft tissue
healing, was recorded at 1 and 3 weeks and 3 and 6
months after surgery. WHI was recorded as the follow-
ing criteria: score 1: uneventful wound healing with
no gingival edema, erythema, suppuration, patient
discomfort, or flap dehiscence; score 2: uneventful
wound healing with slight gingival edema, erythema,
patient discomfort, or flap dehiscence, but no suppu-
ration; and score 3: poor wound healing with signifi-
cant gingival edema, erythema, patient discomfort,
flap dehiscence, or suppuration.
All measurements were performed by the same
calibrated examiner (RN) using a UNC manual probe.
The examiner remained masked to the treatment
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types of all patients for the entire duration of the study.
Calibration was conducted prior to, during, and after
the study to ensure adequate intraexaminer reliability.
The k value of the examiner was 88% before the proj-
ect had started, 89% during the project period, and
91% after the project was completed.
Vertical defect fill was calculated from the change
of distances measured from the reference point on
the stent to the base of defect. Crestal bone resorption
was calculated by subtracting vertical bone fill from
the change of defect depth.
Surgical Protocol
The surgical procedure included the elevation of a full-
thickness mucoperiosteal flap with intracrevicular in-
cisions with two vertical releasing lines, preserving as
much keratinized tissue as possible without engaging
the interdental papillae.The furcationdefects were de-
brided, and all root surfaces were completely scaled
and root planed by hand, ultrasonic, and rotating
instrumentation.§ Cemento-enamel projection was
removed by enamel plastic buri if present. After de-
bridement (Fig. 2), patients were randomized into
one of the three groups: 1) MBA alone; MBA was
mixed with normal saline and placed in the furcation
area (Fig. 3); 2) GTR + MBA; after MBA placement,
collagen membrane¶ was trimmed to cover the defect
2 mm beyond the edge of furcation defect; and 3)
OFD alone; all surgical procedures were identical ex-
cept that no bone graft or membrane was placed. The
membrane was sutured with 5-0 chromic gut sutures#
using the sling suture technique. The flap was sutured
securely to its original position with 5-0 polyglactin
910,** with care to ensure that no bone graft or mem-
brane was left exposed. In the OFD-treated sites, the
furcations were covered by repositioning the flaps.
None of the furcations were exposed after treatment.
Postoperative Care
All patients received routine, written, and oral postop-
erative instructions and were instructed to rinse with
0.12% chlorhexidine gluconate for a period of 3 to 4
weeks. Sutures were removed 7 to 10 days after sur-
gery. Patients returned in 3 weeks after surgery for ob-
servation of any adverse tissue reactions. All patients
received periodontal maintenance at 3 and 6 months.
6-Month Reentry Surgery
At the end of 6 months, the patients were scheduled
for reentry surgeries. Clinical measurements (GI, PI,
Figure 1.
The method to measure the furcation defect during surgery: 1) stent
to the base of defect (BD); 2) alveolar crest (AC) to the base of
defect; 3) HDD in bucco-lingual direction; and 4) HDW in
mesio-distal direction. CEJ = cemento-enamel junction.
Figure 2.
Debridement of the furcation defect.
Figure 3.
Mineralized bone allograft in place.
§ Nemeyer’s bur, Brasseler USA, Small Parts, Miami Lakes, FL.
i Brasseler USA, Small Parts.
¶ BioMend Regular, Zimmer Dental, Carlsbad, CA.
# Ethicon, Johnson & Johnson, Somerville, NJ.
** Vicryl, Ethicon, Johnson & Johnson.
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vertical probing depth [VPD], CAL, WHI, HPD, stent to
the free gingival margin, SB, CB, BL/MD morphology
of defect, and mobility) of the involved tooth were
recorded. The incisional design was the same as the
initial surgery. In patients with other periodontal prob-
lems in the same quadrant, a full quadrant periodontal
surgery was performed as indicated. Full-thickness
mucoperiosteal flaps were reflected to expose the pre-
viously treated furcation areas for clinical measure-
ments as previously described. Patients were seen
1 week after surgery for suture removal and then
placed on a closely supervised schedule for periodon-
tal maintenance.
Statistical Analysis
Power calculations (a mean difference of 0.66718 was
used in the calculation) were performed before the
study was initiated. To achieve 80% power and detect
mean differences of the clinical parameters between
groups, 10 subjects in each group were required. The
data collected on continuous variables were pre-
sented as mean –SD for different groups and analyzed
using a statistical software program.††
The paired t test and Wilcoxon signed rank test
were used to analyze continuous parameters, i.e.,
VPD, HPD, and CAL, before and after treatment within
the groups. The Wilcoxon signed rank test was applied
tocomparediscrete parameters, i.e., PI, GI, and WHI, at
different time points within the groups. The paired t test
and repeated measures analysis of variance (ANOVA)
were used to compare the three groups in terms
of mean differences over time on the various measures
collectedatbaselineand6months (e.g.,VPDandCAL).
The repeated measures ANOVA were used to com-
pare the three groups in terms of mean differences
over time on the various measures collected during
surgery (first and second surgeries). The Kruskal-
Wallis test and general linear models (GLM) ANOVA
were used to compare the mean of clinical parameter
improvement over time (e.g., percentage of improve-
ment in vertical defect depth (VDD) and millimeters of
improvement in VDD) between different treatment
groups. The paired t test and repeated measures
ANOVA were used to compare the three groups in
terms of the mean difference of clinical measurements
(e.g., horizontal defect depth [HDD]-BL, VDD, CAL,
and VPD) over time (baseline and 6 months). All tests
of hypotheses were two-sided, and differences were
considered statistically significant when P <0.05 with
a 95% level of confidence.
RESULTS
Demographic Results (Table 1)
Out of a total of 30 subjects, 27 patients (12 females
and 15 males; mean age: 54.4 – 9.8 years) completed
the study. A total of 21 buccal and six lingual furca-
tions (four in OFD and two in MBA groups) in mandib-
ular molars (22 first molars and five second molars)
were treated. The distribution of tooth type was similar
among groups.
Baseline Measurements
There were no statistically significant differences
of baseline clinical parameters among the groups
(P >0.05) (Tables 2 through 5).
Intragroup Comparisons
No serious postoperative complications were reported
or observed throughout the entire study. Six months
after initial surgery, the reduction of VPD was statisti-
cally significant in the MBA group (P <0.05) and mar-
ginally significant in the GTR + MBA group (P = 0.08)
(Table 2). The reduction of HPD was statistically sig-
nificant in the GTR + MBA group (P <0.05) and mar-
ginally significant in the MBA group (P = 0.07). The
mean difference of CAL showed no significant differ-
ence in any group over time. The GI decreased in all
groups compared to baseline (P <0.05) (Table 3).
The PI and BOP did not show statistically significant
differences in any group over time. The reductions
of HDD and vertical bone fill were statistically signifi-
cant in the MBA and GTR + MBA groups (P <0.05)
(Tables 4 and 5). The horizontal defect width (HDW)
decreasedsignificantlyonly in theMBAgroup(P<0.05)
(Table 4). No statistically significant difference of WHI
between any two time points was found.
Intergroup Comparisons
At the 6-month follow-up, six out of 27 patients (22.2%)
had converted to Class I furcations, whereas others
remained Class II (Table 6). The remaining vertical
defect depth measured at reentry was 1.0 mm in the
MBA group, 1.6 mm in the GTR + MBA group, and
3.0 mm in the OFD group (Table 5). However, no sta-
tistical difference was noted among groups. Similarly,
no differences in crestal bone resorption among groups
were found (Table 5). The remaining HDD at reentry
was 4.6 mm in the OFD group and 3.2 mm in the MBA
and GTR + MBA groups, with no statistically signifi-
cant differences (Table 4). A similar result was also
found in the HDW (Table 4).
When examining the vertical bone fill (Fig. 4), the
MBA and the GTR + MBA groups showed significant
improvement, whereas the OFD group had a loss of
vertical bone height (Table 5). A statistically signifi-
cant difference was found between the MBA and
OFD groups (P <0.05) and between the GTR + MBA
and the OFD (P <0.05) groups with regard to vertical
bone fill (Table 5). When comparing the vertical bone
fill in percentage, the MBA group had a significantly
higher percentage of vertical bone fill than the OFD
group (48.9% versus 5.6%, respectively; P <0.05).
†† SPSS version 12.0, SPSS, Chicago, IL.
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However, no difference was noted between the GTR +
MBA and the OFD groups (38.3% versus 5.6%, re-
spectively) (Table 7). The horizontal bone fill was
0.2 – 1.7 mm (14.7 – 19.7%) in the OFD group, 1.1
– 0.9 mm (24.6 – 21.4%) in the MBA group, and
1.1 – 0.9 mm (23.9 – 17.2%) in the GTR +MBA group,
with no statistically significant differences noted
among groups (Tables 4 and 8). The recession and
CAL improvement at furcation showed no significant
differences among groups.
Correlation of HPD and HDD
Measurements (Table 9)
The correlations between HPD prior to surgery and
open HDD measurements during surgeries (both ini-
tial and reentry) were analyzed. The correlation was
Table 1.
Baseline Demographic Results
Total (N = 27) OFD (n = 9) MBA (n = 9) GTR + MBA (n = 9)
Age (years) (mean – SD [range]) 54.4 – 9.8 (30 to 77) 48.8 – 3.1 (30 to 65) 57.7 – 3.1 (42 – 77) 56.7 – 3.1 (43 – 69)
Gender* F = 12 F = 5 F = 3 F = 4
M = 15 M = 4 M = 6 M = 5
Location of furcation† B = 21 B = 5 B = 7 B = 9
L = 6 L = 4 L = 2 L = 0
Tooth‡ FM = 22 FM = 7 FM = 8 FM = 7
S = 5 S = 2 S = 1 S = 2
* F = female; M = male.
† B = buccal; L = lingual.
‡ FM = first molar; S = second molar.
Table 2.
Clinical Measurements at Furcation Site (mean – SD [mm])
VPD HPD CAL
Group Baseline 6 Months Difference Baseline 6 Months Difference Baseline 6 Months Difference
OFD 4.7 – 0.9 4.5 – 0.9 -0.1 – 1.1 4.7 – 1.7 3.8 – 1.6 -0.9 – 1.9 5.4 – 1.3 6.3 – 1.8 0.9 – 1.6
MBA 4.3 – 1.8 3.4 – 1.4 -0.9 – 0.9* 3.9 – 1.1 2.7 – 1.4 -1.2 – 1.9† 5.1 – 2.8 5.0 – 1.9 -0.1 – 1.0
GTR + MBA 4.6 – 1.1 3.9 – 1.5 -0.7 – 1.0‡ 4.2 – 1.2 3.1 – 1.2 -1.1 – 0.5* 5.2 – 2.0 5.6 – 2.4 0.3 – 1.2
* Statistically significant, P <0.05; Wilcoxon signed rank test.
† Borderline significance, P = 0.07; Wilcoxon signed rank test.
‡ Borderline significance, P = 0.08; Wilcoxon signed rank test.
Table 3.
Clinical Parameters at Furcation Sites (mean – SD)
GI PI BOP
Group Baseline 6 Months Difference Baseline 6 Months Difference Baseline 6 Months Difference
OFD 1.7 – 0.5 0.3 – 1.5 -1.3 – 0.5* 1.1 – 0.8 1.0 – 0.5 -0.1 – 0.8 1.0 – 0.0 0.7 – 0.5 -0.3 – 0.5
MBA 1.6 – 0.5 0.7 – 0.7 -0.9 – 0.6* 0.9 – 0.6 1.0 – 0.7 0.1 – 1.2 0.8 – 0.4 0.4 – 0.5 -0.3 – 0.5
GTR + MBA 1.4 – 0.7 0.3 – 0.7 -1.1 – 0.9* 1.0 – 0.9 0.6 – 0.7 -0.4 – 1.4 0.9 – 0.3 0.6 – 0.5 -0.3 – 0.7
* Statistically significant, P <0.05; Wilcoxon signed rank test.
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0.80 at baseline and 0.77 at 6 months. No significant
difference between HPD and HDD was found at base-
line (4.2 – 1.3 mm versus 4.5 – 1.2 mm, respectively,
P >0.05). However, at 6 months, the measurement
of HPD was significantly lower than HDD (3.2 –
1.4 mm versus 3.7 – 1.4 mm, P <0.05). This implied
that bone sounding is more
accurate in diagnosing furca-
tions prior to surgery than
after treatment.
DISCUSSION
Methods for the treatment
of furcation-involved molars
have shown varying degrees
of success.7-10 Limited in-
formation is available with
regard to the use of solvent-
preservedhumanMBAasbone
replacement material for the treatment of furcation
defects. The benefit of a bioabsorbable membrane
(e.g., collagen membrane) in treating Class II furca-
tion defects over OFD has been reported.7-9,18,22
Nevertheless, data were lacking when examining
the effects of MBA with or without bioabsorbable col-
lagen membrane for management of Class II furca-
tion defects. Therefore, the purpose of this study was
aimed at evaluating the capability of MBA with and
without bioabsorbable collagen membrane for regen-
erating mandibular Class II furcation defects. A histor-
ical study performed at the University of Michigan that
compared bioabsorbable collagen membrane alone
to OFD in treating Class II furcations was used as a
historical control for the collagen membrane alone
group.18
Results obtained from this study indicated the pos-
itive effects of MBA and GTR + MBA for the treatment
of furcation defects, especially vertical defect fill. The
improvement of vertical bone level was significant in
the MBA (1.9 mm) and GTR + MBA (0.7 mm) groups,
whereas the OFD group lost 1.6 mm of vertical height.
In a study using collagen membrane in treating fur-
cations, similar vertical bone fill (0.7 mm) in a GTR
group was found.23 The differences between the
MBA and OFD, GTR + MBA, and OFD groups in ver-
tical bone fill were clinically significant because it was
more than standard deviation of probe measurement.
Similar findings were also reported by Kenney et al.24
when porous hydroxylapatite was used as a grafting
material in treating Class II furcations (a 2.0-mm gain
of vertical fill in bone graft sites versus a 0.3-mm loss
of height in OFD sites). The effect of bone replace-
ment graft (BRG) with demineralized freeze-dried
bone allograft (DFDBA) and citric acid in treating
Class II furcations reported by Gantes et al.25 showed
a similar vertical bone fill of 2.4 mm. Our data were
also in agreement with Couri et al.26 However, several
studies demonstrated minimal bone fill only, ranging
from 0.1 to 0.4 mm, in the BRG or GTR or BRG + GTR
groups.27-29 Different membranes (e.g., collagen
membrane in this study) or bone grafts (e.g., mineral-
ized human cancellous bone) used may explain the
Table 4.
Defect Measurements During Surgeries (mean – SD [mm])
HDD HDW
Group Baseline 6 Months Difference Baseline 6 Months Difference
OFD 4.7 – 1.4 4.6 – 1.6 0.2 – 1.7 3.4 – 0.5 3.4 – 0.7 0.0 – 0.5
MBA 4.3 – 0.8 3.2 – 1.0 1.1 – 0.9* 3.7 – 0.7 3.0 – 0.5 -0.7 – 0.7*
GTR + MBA 4.4 – 1.4 3.2 – 1.1 1.1 – 0.9* 3.2 – 0.4 3.0 – 0.7 -0.2 – 0.8
* Statistically significant, P <0.05; Wilcoxon signed rank test.
Table 5.
Vertical Bone Level Measurements During
Surgery (mean – SD [mm])
Baseline 6 Months
Crest of bone to base of defect
OFD 2.9 – 1.3 3.0 – 2.3
MBA 4.0 – 1.0 1.0 – 1.6
GTR + MBA 2.8 – 1.8 1.6 – 1.9
Vertical bone fill*




†MBA 1.9 – 1.4
GTR + MBA 0.7 – 0.9
Crestal bone resorption
OFD 1.4 – 1.4
MBA 1.3 – 1.1
GTR + MBA 0.7 – 0.9
* Results of Kruskal-Wallis test: There is evidence of a significant difference
of the mean of vertical bone fill between MBA and OFD (P = 0.002) and
between GTR + MBA and OFD (P = 0.016).
† Statistically significant, P <0.05.
Table 6.
Distribution of Furcation Closure
at 6 Months
OFD MBA GTR + MBA
Class 0 0 0 0
Class I 1 3 2
Class II 8 6 7
Class III 0 0 0
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different results obtained. Mineralized human cancel-
lous allograft retains the mineral, collagen structures,
and trabecular patterns of the bone. These character-
istics, with the high porosity and increased inner sur-
faces on the grafts, may facilitate osteoconductivity
beyond other bone graft materials. Therefore, the
higher amount of bone formation could be observed
when MBA is used. Additional placement of collagen
membrane over MBA could promote PDL fibroblast
and osteoblast cell adhesion and enhance periodontal
regeneration via collagen membrane hemostatic and
chemotactic function.30 This may explain the positive
results obtained in the GTR + MBA group. It is not sur-
prising to note that OFD treatment resulted in a loss of
vertical bone (1.6 mm in our study, and others have
shown 0.2 to 1.0 mm of bone loss).28,31 This is further
supported by the evidence that showed crestal bone
loss is often unavoidable after a full-thickness flap re-
flection.32,33 Due to the furcation defect morphology
(it is always surrounded by two roots), this implies
1- or 2-wall osseous defects for most furcation de-
fects. These types of bony defects do not favor bone
fill after OFD. Although several studies suggested that
the combination of BRG and GTR provided the best
results in furcation treatment,34-37 some have also
questioned the advantage of using this combination
approach.29 As discussed in recent systematic re-
views,9,10 it is not possible to compare the outcomes
from different barrier and grafting materials due to the
limited controlled clinical trials available.
There were three dropouts in the present study, and
they were equally distributed, one subject from each
group. This was indicated and described in Table
1 (as illustrated, the final subject number was nine
in each group). Future studies are encouraged to
add 10% more subjects to accommodate the potential
patient dropout. Although there were different teeth
treated and locations (buccal versus lingual) of furca-
tions, no statistical difference was found when com-
paring these variables (first versus second molars;
buccal versus lingual furcation defects). The location
of furcation defects may influence the ability of pa-
tients to clean these areas. However, when data were
analyzed, no difference in plaque index (index to as-
sess the hygiene ability of patients) was found, which
indicated that the location of furcation did not influ-
ence the ability of patients to clean the area.
When comparing the outcome of the study to the
historical GTR study,38 there was a significant differ-
ence between the results reported in the control
groups. Vertical bone fill in the OFD group was 1.5
Figure 4.
Bone fill in furcation was observed.
Table 7.
Vertical Bone Fill (%) and Comparison
Among Treatment Groups
Group Mean – SD (%) 0% to 25% 26% to 50% >50%
OFD 5.6 – 16.7 8 1 0
MBA* 48.9 – 34.1 3 4 2
GTR + MBA 38.3 – 40.9 5 1 3
* Results of Kruskal-Wallis test: x2 (2) = 9.160; P = 0.010; results of GLM
ANOVA: P = 0.026 when comparing MBA to OFD. There is evidence of a
significant difference of the mean of vertical bone fill between MBA and
OFD.
Table 8.
Horizontal Bone Fill (%) and Comparison
Among Treatment Groups
Group Mean – SD (%) 0% to 25% 26% to 50% >50%
OFD 14.7 – 19.7 7 2 0
MBA 24.6 – 21.4 7 1 1
GTR + MBA 23.9 – 17.2 5 4 0
There was no statistically significant difference among groups; results of
Kruskal-Wallis test: x2 (2) = 1.146; P = 0.564.
Table 9.
Comparison of HPD and HDD
Mean – SD (mm) Correlation* P Value*
HPD-1 4.2 – 1.3 0.80 0.109
HDD-1 4.5 – 1.2
HPD-2 3.2 – 1.4 0.77 0.013†
HDD-2 3.7 – 1.4
1 = measurement at initial surgery; 2 = measurement at reentry.
* Based on paired sample t test.
† Statistically significant, P <0.05.
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mm and 2.5 mm in the GTR alone group from the his-
torical study.38 Due to the variation of outcomes ob-
tained in our control group, it was impossible to use
the historical data to compare the outcome to the pres-
ent study. Therefore, no comparisons were attempted
to differentiate the outcome differences among the
GTR, MBA, and GTR + MBA groups.
The present study also demonstrated a horizontal
bone fill of 1.1 mm in the MBA and GTR +MBA groups,
whereas it was only 0.2 mm in the OFD group. This is
in agreement with early studies that showed minimal
horizontal bone fill after treatment in furcation
defects.27,28,39 Our data also supported the data
reported by Kenney et al.,24 who demonstrated a
1-mm horizontal bone fill in a BRG group.24 Further-
more, the horizontal bone fill in a recent study using
GTR +BRG illustrated a similar percentage of horizon-
tal bone fill compared to ours (23.8% versus 23.9%).26
From the systematic review by Jepsen et al.,9 the
mean difference of horizontal defect fill between the
GTR and OFD groups was 0.87 mm when combined
with mandibular and maxillary molars; however, it
was 1.51 mm when only mandibular molars were in-
cluded. The outcome of the present study was slightly
less favorable but close to results reported in the meta-
analysis.
The lack of sufficient bone formation to fill any of
the furcation defects indicated the low predictability
of the procedure. This agrees with the majority of stud-
ies that showed inconsistency of complete furcation
closures.7,9,40 From the recent systematic review,9
only one case out of eight reentry studies showed
complete furcation fill among cited randomized con-
trolled trials of GTR in furcations. Furthermore, one re-
cent study showed three out of 45 GTR treated cases
had complete furcation closure in 14 months.41 None-
theless, complete furcation closure was reported by
studies using clinical measurements (e.g., PD and
CAL).42 The inconsistency noted between clinical and
reentry measurement may explain this difference.39
New connective tissue attachment may form without
a concomitant buildup of the alveolar bone.39,43
Those studies indicated that bone changes at furca-
tions cannot be properly assessed without reentry,
and conclusions drawn from clinical measurements
of gingival recession, probing depth, and attachment
level may be problematical.39 In the current study, no
furcation was completely filled with bone, and a hor-
izontal component of the bone lesion was always pres-
ent at reentry. If complete bone fill of a furcation is
considered the goal of regenerative treatment, then
the procedure was not successful in any single case.
On the other hand, the study demonstrated that partial
bone regeneration is possible. To what extent such
partial gain promotes the longevity of the tooth re-
mains to be studied.
The accuracy of the clinical diagnosis of the furca-
tions has been debated from different studies. It was
reported to be overestimated and inaccurate in some
studies.36,44 The results from this study suggested
that furcation diagnosis with bone sounding can accu-
rately estimate bone levels as determined at the time
of surgery in the inflamed periodontal tissue. Studies
using clinical probing to conclude furcation closure
might lead to an overestimation of the clinical out-
come by feeling resistance of the reattachment, new
attachment, or even granulation tissues instead of
true bone fill.
There was a significant reduction of vertical prob-
ing depth (0.9 mm) in the MBA group at 6 months
compared to baseline. Although the GTR + MBA
and OFD groups also had minimal VPD reduction,
no statistically significant difference was noted. This
is less favorable than the conclusion from the system-
atic review reported by Murphy and Gunsolley,8 which
showed GTR had more reduction in vertical probing
depth compared to OFD controls. But our data in the
GTR +MBA group are similar to the results of the study
by Couri et al.26 Data obtained in this study are also in
agreement with Andersson et al.45 and Cury et al.;22
changes of vertical CAL at furcation sites between
baseline and 6 months were not statistically signifi-
cant in all groups. All groups in our study showed im-
provement in HPD. However, the improvement was
statistically significant only in the GTR + MBA group
(P <0.05) and was marginally significant in the MBA
group (P = 0.07). No specific conclusion regarding
the improvement of HPD could be drawn from the re-
cent systematic reviews, due to the heterogeneity
among the studies cited.8,10 Nonetheless, our data
are similar to those from previous studies by Caffesse
et al.27 and Black et al.46 in the GTR and OFD groups.
The wound healing index was developed by our
group to assess soft tissue healing after periodontal/
implant surgery. The index is designed to quantitate
the soft tissue response. It has been shown to be a
reliable index for assessing soft tissue response after
surgery.21 Slight edema means a slightly greater
swelling than the normal knife-edge tissue. Significant
edema means an obvious swelling. The score is de-
signed for assessing soft tissue response; slight dehis-
cence and slight edema were grouped into the same
score.
Adverse tissue reaction or infection was not ob-
served following any of the surgical procedures in
the study. The bone graft material and bioabsorbable
collagen membrane used in the study appear to be
biocompatible and safe. Membrane exposure was
not observed in any of the cases in the study. This
may be explained by the biocompatibility of the colla-
gen membrane and its hemostatic and chemotactic
functions.47-50 The hemostatic function will enhance
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early wound stabilization and clot formation. This
indirectly promotes better flap adaptation, thus re-
sulting in less membrane exposure. Furthermore,
the chemotactic function of the collagen membrane
promotes fibroblast migration that ensures primary
wound coverage can be facilitated.
A major question was whether partial improvement
in mandibular Class II furcations, such as shown in this
studyandothers,7 improves theprognosisof the tooth.
Higher chances of bone fill were found in moderate de-
fects, rather than deep Class II defects in this study.
Similar trends were also reported by others.29,42 How-
ever, the treatment outcome facilitating the ability of
patients to perform better plaque control or the ability
of clinicians to maintain the tooth remains undecided.
The outcomeof the present study indicates that regen-
erative therapy in mandibularClass II furcationdefects
with human mineralized bone allograft with or without
bioabsorbable membrane provided additional benefits
over open flap debridement alone. MBA was shown
to improve bone fill significantly in Class II furcations.
The benefits of the additional use of a GTR barrier could
not be justified in this study because both MBA groups
hadcomparableresults.Futurestudieswith largersam-
ple sizes, strict case selections, and longer follow-ups
are certainly encouraged.
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